Practice Research Database News Today

The show must go on. In yourfront garden. Actors are performing west end shows on doorsteps while theatres are closed. Sensational salah. Mo becomes liverpools all time record goal scorer in the Champions League, on a night when results were less important with liverpool and Manchester City already group winners. Good morning from kew gardens where it is christmas at kew gardens and there are over1 million twinkling lights on the trail and we are standing right in front of the rose garden. Not a...

— NDA accepted and granted Priority Review following its Breakthrough Therapy designation granted in January 2022 —— NDA is supported by data from successful Phase III ESLIM-01 trial in patients with adult primary immune thrombocytopenia who have received at least one previous therapy — ...

— Randomized, double-blind, controlled trial met primary endpoint of durable response rate and all secondary endpoints — — Overall safety consistent with sovleplenib known profile — —...

— Randomized, double-blind, controlled trial met primary endpoint of durable response rate and all secondary endpoints — — Overall safety consistent with...

By John Stone Heidi Larson, the director of Vaccine Confidence Project, was seen and heard on the BBCs Victoria Derbyshire Show on Friday morning. Here is an extract: HL: Well, I think the main thing is there most incredibly extensive...

News and opinion relevant to families raising children with autism into adulthood and beyond.

Patients with COVID-19 have an elevated risk for cardiovascular events and death, particularly if hospitalized, a retrospective analysis suggests. The risk was higher in the first 30 days after infection.

By John Stone I recently wrote to Dame Sally Davies, Chief Medical Officer of England and to the British government, asking her for the basis of her statement to the BBC regarding MMR: "Its a safe vaccination - we know...

A study of data from over 11 million patient records in the General Practice Research Database, "the largest anonymized, longitudinal primary care database

Investegate announcements from Hutchmed China Ltd, HUTCHMED Initiates Phase III Trial of HMPL-523